Dr. Douglas Allen Arenberg is a pulmonologist and critical care doctor with the University of Michigan Health and the University of Michigan Medical School. In addition to his role as Professor of Internal Medicine, Dr. Arenberg is the Medical Director of the Pulmonary Medical Procedures Unit at Michigan. Dr. Arenberg specializes in critical care medicine and diagnosing, staging, preventing, and early detection of lung cancer. He is experienced in bronchoscopy and other state-of-the-art treatments for diseases of the lungs.
His interests are narrowly focused on patients with known or suspected lung cancer. He is the Medical Director of the facility’s Lung Cancer Screening Program and works as part of a multidisciplinary team to analyze the unique aspects of each patient’s health, priority, and needs in order to arrive at a patient-specific approach that offers hope for length of life and quality of life.
Education and Career
Dr. Arenberg attended the University of Illinois for his undergraduate years, and after earning a bachelor of science in Bioengineering, he moved on to the school’s College of Medicine to pursue his medical degree. After graduation, he pursued an internship and residency in Internal Medicine at the University of Michigan Health System and later completed a fellowship in Pulmonary Disease and Critical Care Medicine there.
In addition to his roles at the University of Michigan Medical School, Dr. Arenberg spent eight years serving as Associate Editor of Respiratory Medicine. He is a member of the Tobacco Cessation Guidelines Committee of the National Comprehensive Cancer Network and a board member of the American College of Chest Physicians Board of Regents, and currently serves as Associate Editor: of Thoracic Oncology for CHEST: The Official Journal of the American College of Chest Physicians. He is frequently invited to speak and present at medical conferences and has authored and co-authored hundreds of journal articles and multiple books and book chapters.
Dr. Arenberg is a member of many professional organizations, including:
- American Association for Cancer Research
- American College of Physicians
- American Federation for Medical Research
- American Thoracic Society
- Central Society for Clinical Research
- Fellow of the American College of Chest Physicians
- International Association for the Study of Lung Cancer
Dr. Arenberg is actively involved in clinical research and is particularly interested in angiogenesis and the role of migration inhibitory factor (MIF) in cancer, tumor microenvironment, and its influence on tumor biology. He is also engaged in studying the impact of lung cancer screening, early detection of lung cancer, and risk biomarkers.